A61K 51/10
Antibodies or immunoglobulins
Official title: Antibodies or immunoglobulins; Fragments thereof {, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody}
A61K51/10 (Antibodies or immunoglobulins) appears on 1,981 US grants and 2,643 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,981
- Published applications
- 2,643
- Assignees
- 962
- Inventors
- 4,120
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 9 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 11 | 0 |
| 1988 | 11 | 0 |
| 1989 | 30 | 0 |
| 1990 | 28 | 0 |
| 1991 | 32 | 0 |
| 1992 | 46 | 0 |
| 1993 | 36 | 0 |
| 1994 | 33 | 0 |
| 1995 | 34 | 0 |
| 1996 | 32 | 0 |
| 1997 | 53 | 0 |
| 1998 | 53 | 0 |
| 1999 | 43 | 0 |
| 2000 | 41 | 0 |
| 2001 | 33 | 14 |
| 2002 | 27 | 46 |
| 2003 | 24 | 68 |
| 2004 | 30 | 82 |
| 2005 | 20 | 76 |
| 2006 | 32 | 74 |
| 2007 | 26 | 78 |
| 2008 | 39 | 69 |
| 2009 | 52 | 105 |
| 2010 | 55 | 112 |
| 2011 | 59 | 97 |
| 2012 | 65 | 110 |
| 2013 | 71 | 104 |
| 2014 | 80 | 147 |
| 2015 | 89 | 133 |
| 2016 | 93 | 153 |
| 2017 | 104 | 138 |
| 2018 | 85 | 113 |
| 2019 | 77 | 113 |
| 2020 | 78 | 119 |
| 2021 | 56 | 97 |
| 2022 | 65 | 126 |
| 2023 | 59 | 110 |
| 2024 | 57 | 162 |
| 2025 | 62 | 94 |
| 2026 | 37 | 103 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61K 51/1045Against animal or human tumor cells or tumor cell determinants805
- A61K 51/1093Conjugates with carriers being antibodies691
- A61K 51/1027Against receptors, cell-surface antigens or cell-surface determinants479
- A61K 51/1018Against material from animals or humans188
- A61K 51/1084The antibody being a hybrid immunoglobulin107
- A61K 51/1021Against cytokines69
- A61K 51/1075The antibody being against an enzyme65
- A61K 51/1078The antibody being against an immunoglobulin, i.e. being an -anti-idiotypic antibody20
All 13 subgroupsShow fewer
Recent patents
- Antibody conjugates and uses thereof6 Oct 2026US 12,753,242 B2GlycoNex Inc.
- Urokinase plasminogen activator receptor-targeted radiopharmaceutical22 Sep 2026US 12,741,039 B2Monopar Therapeutics Inc.
- Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer22 Sep 2026US 12,741,964 B2Cornell University
- Compositions and methods of immunodepletion for the treatment of malignant and non-malignant hematological diseases8 Sep 2026US 12,728,176 B2Actinium Pharmaceuticals, Inc.
- DR5 radioimmunotherapy in the treatment of solid cancers1 Sep 2026US 12,721,913 B2Actinium Pharmaceuticals, Inc.
- Development of a platform to noninvasively image car t cells8 Oct 2026US 2026/0306681 A1Dana-Farber Cancer Institute, Inc.
- Radiolabeled met binding proteins for immuno-pet imaging8 Oct 2026US 2026/0306682 A1Regeneron Pharmaceuticals, Inc.
- In vivo imaging of an als biomarker and means therefor8 Oct 2026US 2026/0306683 A1AL-S Pharma AG
- Antibody targeting dll3 and use of antibody8 Oct 2026US 2026/0308240 A1Neukio Biotherapeutics (Shanghai) Co., Ltd.
- Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer1 Oct 2026US 2026/0295100 A1Memorial Sloan Kettering Cancer Center
Most cited
By later US patents
- Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics940US 8,008,449 B2Medarex, Inc. · 2011
- Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers510US 4,331,647 A1982
- Dual variable domain immunoglobulin and uses thereof391US 7,612,181 B2Abbott Laboratories · 2009
- Tumoricidal methotrexate-antibody conjugate378US 4,699,784 ACenter for Molecular Medicine and Immunology · 1987
- Antibody-metal ion complexes348US 4,741,900 ACytogen Corporation · 1988